Amlexanox

This page contains recent news articles, when available, and an overview of Amlexanox but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

작년 日 OTC 시장 �?가세 유지  -  ‎Aug 20, 2009‎
OTC 전환약�?� 후보약물로는 �?� 외�?�?� '암렉사녹스'(amlexanox), '페미로�?�스트칼륨'(pemirolast potassium) 외 7개 성분�?� 제시�?� 있어, 후지경제는 "향후 시장�?� 디지틀보사

10-K: ULURU INC.  -  ‎Mar 30, 2009‎
Amlexanox 5% paste and OraDisc(TM) A were both developed for the treatment of canker sores. Under the terms of the agreement, MEDA made an upfront payment MarketWatch (press release)

10-K: ACCESS PHARMACEUTICALS INC  -  ‎Mar 31, 2009‎
...(2) Includes: Vitamin Mediated Targeted Delivery, carbohydrate targeting, amlexanox cream and gel and other related projects. Due to uncertainties and MarketWatch (press release)

Uluru signs license agreement with Meda AB  -  Nov 17, 2008
...surgery and oral care products, signed a license agreement with Meda AB to provide marketing for Amlexanox 5% paste and OraDisc A throughout Europe. Bizjournals.com,

Meda AB signs collaboration agreement with US company Uluru Inc  -  Nov 17, 2008
Meda will receive exclusive rights to Uluru's products Amlexanox 5% paste and OraDisc A in most European countries in exchange for an up-front payment Trading Markets (press release),

ULU: License Agreement with Meda AB for European Market  -  Nov 17, 2008
ULURU Inc. (ULU) announced the signing of a License Agreement with Meda AB to market Amlexanox 5% paste and OraDisc(TM) A throughout the European Union, Trading Markets (press release),

Europeiskt samarbetsavtal för OraDisc A TM  -  Nov 17, 2008
Meda har ingått ett avtal med Uluru Inc, ett amerikanskt specialty pharmaföretag, för Amlexanox 5% pasta och OraDisc ATM. Avtalet ger Meda exklusiva Newsdesk (pressmeddelande),

日 7개성분 처방약, OTC로 전환  Sep 1, 2008
...�?�본�?서 ‘암렉사녹스’(amlexanox) 등 7개 성분�?� 처방약�?서 OTC로 전환�?�다. �?�본 약사·�?품위�? 심�?�회 �?�반용 �?�약품 부회는 내복용 알레르기성 비염 치료제디지틀보사,

Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.